Benitec Biopharma Inc.
BNTC
$11.50
-$0.18-1.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.04% | 44.48% | -72.62% | 2.07% | -88.81% |
| Total Depreciation and Amortization | 1.69% | 0.00% | 11.32% | 30.86% | -10.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.45% | -61.49% | 417.94% | 9.39% | 445.75% |
| Change in Net Operating Assets | 77.85% | 105.61% | -258.06% | 688.28% | -1,043.40% |
| Cash from Operations | -12.68% | 59.20% | -166.14% | 59.94% | -67.97% |
| Capital Expenditure | -- | -- | 100.00% | 50.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | 50.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -17.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -206.18% | 1,874,300.00% | -- |
| Cash from Financing | -- | -- | -91.05% | 59.00% | -17.49% |
| Foreign Exchange rate Adjustments | -253.49% | 171.67% | -471.43% | -107.37% | 400.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,988.55% | 43.60% | -122.88% | 142.35% | -38.50% |